Form 4: Hologic Merger Completes, Insider Ownership Changes

Hologic Inc. announces the completion of its merger, leading to significant changes in beneficial ownership for reporting persons.

Summary

• This filing reports changes in beneficial ownership for Charles J. Dockendorff, a Director at Hologic Inc. (HOLX).
• The changes are a result of the completion of a merger between Hologic, Inc. and Hopper Parent Inc. (through its subsidiary Hopper Merger Sub Inc.).
• Effective April 7, 2026, Hologic, Inc. merged with Merger Sub, with Hologic surviving as a wholly owned subsidiary of Parent.
• Each share of Hologic common stock was converted into $76.00 in cash and one contingent value right (CVR) potentially worth up to $3.00.
• As a result of the merger, the reporting person no longer beneficially owns any shares of Hologic common stock directly or indirectly.
• Options to purchase Hologic common stock were cancelled and converted into cash payments and/or CVRs, depending on their exercise price relative to the merger consideration.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on the completion of a merger and the resulting changes in ownership for an insider, rather than new operational or financial performance data.

Positives

• The merger has been successfully completed, providing shareholders with cash and contingent value rights.
• The transaction offers a clear cash payout of $76.00 per share, plus potential additional value from CVRs.

Negatives

• The reporting person, Charles J. Dockendorff, no longer holds any direct or indirect beneficial ownership of Hologic common stock.
• Options with exercise prices at or above the sum of cash consideration and $3.00 were cancelled for no consideration.

Risks

• The value of the contingent value rights (CVRs) is not guaranteed and depends on future events and conditions, as outlined in the merger agreement.
• The filing does not detail the specific conditions under which the CVRs will become payable or their estimated probability of payment.

Future Outlook

The future outlook for the reporting person is no longer tied to Hologic's stock performance as their beneficial ownership has ceased. The value of the contingent value rights (CVRs) will depend on the achievement of specific milestones outlined in the merger agreement.

Industry Context

StockSavvy.ai notes that this Form 4 filing is typical following the completion of a significant M&A transaction, where insider holdings are converted into cash and contingent rights, reflecting a common outcome in the biotechnology and medical device sector during periods of consolidation.

Stakeholder Impact

• Shareholders: Receive $76.00 per share in cash and one CVR, representing a liquidity event.
• Option Holders: Options are converted into cash and/or CVRs based on their exercise price.
• Employees (including reporting person): Beneficial ownership of company stock is converted into cash and/or CVRs.

Next Steps

• Shareholders and option holders will receive the merger consideration (cash and CVRs) as per the merger agreement.
• The contingent value rights (CVRs) may provide additional payments if certain conditions are met.

Key Dates

Keywords

Hologic Inc., HOLX, Merger, SEC Form 4, Beneficial Ownership, Insider Trading, Stock Options, Contingent Value Rights, Charles J. Dockendorff, Corporate Governance